MMR: where are we now?

Elliman, David; Bedford, Helen
December 2007
Archives of Disease in Childhood;Dec2007, Vol. 92 Issue 12, p1055
Academic Journal
The article explores the issue regarding the study on a link between bowel disease and autism and mumps, measles, rubella (MMR) vaccine. The vaccine rose rapidly to a high of 92%. In 1992, brands containing the Urabe strain of the mumps vaccine virus were withdrawn after it was noted to be associated with an increased risk of aseptic meningitis. It has been stated that the majority opinion among the researchers involved in this study supports the continuation of MMR vaccination. It has been believed that vaccination against the measles, mumps, and rubella infections should undoubtedly continue but until this issue is resolved by further research.


Related Articles

  • Conjugate Meningococcal Vaccines: Lifesaving or Inefficient Use or Both-No Easy Answer. Pelton, Stephen I. // Clinical Infectious Diseases;1/15/2010, Vol. 50 Issue 2, p192 

    The article presents the editor's views regarding an article about effectiveness of conjugate meningococcal vaccines. He argues that the issue regarding this is not the need for prevention of invasive meningococcal disease but rather the approach. He sees that adolescent vaccination programs are...

  • Incidence of bacterial meningitis (2001-2005) in Lazio, Italy: the results of a integrated surveillance system. Rossi, Paolo Giorgi; Mantovani, Jessica; Ferroni, Eliana; Forcina, Antonio; Stanghellini, Elena; Curtale, Filippo; Borgia, Piero // BMC Infectious Diseases;2009, Vol. 9 Issue 1, Special section p1 

    Background: Monitoring the incidence of bacterial meningitis is important to plan and evaluate preventive polices. The study's aim was to estimate the incidence of bacterial meningitis by aetiological agent in the period 2001-2005, in Lazio Italy (5.3 mln inhabitants). Methods: Data collected...

  • Pandemic Influenza's 500th Anniversary. Morens, David M.; Taubenberger, Jeffery K.; Folkers, Gregory K.; Fauci, Anthony S. // Clinical Infectious Diseases;12/15/2010, Vol. 51 Issue 12, p1442 

    It is impossible to know with certainty the first time that an influenza virus infected humans or when the first influenza pandemic occurred. However, many historians agree that the year 1510 A.D.-500 years ago-marks the first recognition of pandemic influenza. On this significant anniversary it...

  • Neisseria meningitidis Strains Isolated from Invasive Infections in France (1999--2002): Phenotypes and Antibiotic Susceptibility Patterns. Antignac, Aude; Ducos-Galand, Magaly; Guiyoule, Annie; Pirés, René; Alonso, Jean-Michael; Taha, Muhamed-Kheir // Clinical Infectious Diseases;10/1/2003, Vol. 37 Issue 7, p912 

    Examines the total number of clinical isolates of Neisseria meningitidis strains from invasive infections in France. Reduction of the susceptibility to penicillin G; Characteristics of antibiotic-resistant invasive meningococcal isolates; Molecular analysis of penA gene polymorphism.

  • Epidemiology of meningococcal disease in Switzerland, 1999–2002. Ruedin, H. Jaccard; Ninet, B.; Pagano, E.; Rohner, P. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2004, Vol. 23 Issue 7, p517 

    In Switzerland, immunisation against serogroup C meningococcal disease is recommended for persons at increased risk but is not included in the national vaccination programme. The aim of this study was to present the nationwide surveillance data on invasive meningococcal disease collected from...

  • Disease Susceptibility to ST11 Complex Meningococci Bearing Serogroup C or W135 Polysaccharide Capsules, North America. Pollard, Andrew J.; Ochnio, Jan; Ho, Margaret; Callaghan, Martin; Bigham, Mark; Dobson, Simon // Emerging Infectious Diseases;Oct2004, Vol. 10 Issue 10, p1812 

    Clusters of meningococcal disease caused by a hyper-invasive lineage of Neisseria meningitidis, the ST11 complex, bearing a serogroup C polysaccharide capsule, have been prominent in Europe and North America since the early 1990s. This situation has led to expensive public health measures for...

  • Mannose-Binding Lectin Accelerates Complement Activation and Increases Serum Killing of Neisseria meningitidis Serogroup C. Jack, Dominic L.; Jarvis, Gary A.; Booth, Clare L.; Turner, Malcolm W.; Klein, Nigel J. // Journal of Infectious Diseases;10/1/2001, Vol. 184 Issue 7, p836 

    The capacity for different lipo-oligosaccharide (LOS) sialylation patterns of Neisseria meningitidis serogroup C to influence the binding and function of the innate humoral component, mannose-binding lectin (MBL), was investigated. By use of flow cytometry and immunogold electron microscopy, a...

  • Public management of an outbreak of group C meningococcal disease in university campus residents. Round, Alison; Evans, Meirion R.; Salmon, Roland L.; Hosein, Ian K.; Mukerjee, Arun K.; Smith, R. William J.; Palmer, Stephen R. // European Journal of Public Health;Dec2001, Vol. 11 Issue 4, p431 

    Focuses on a study on public health management of an outbreak of group C meningococcal disease in university campus residents. Outbreak description and investigation; Clinical and diagnostic characteristics of cases; Risk factors for carriage of Neisseria meningitidis.

  • School-Based Measles Outbreaks: Correlation of Age at Immunization with Risk of Disease. Gudelsohn, Richard G.; Fleissner, Mary Lou; O'Mara, Dennis J. // American Journal of Public Health;Nov80, Vol. 70 Issue 11, p1162 

    Abstract: During the Spring of 1978, students with a history of previous measles vaccination accounted for over three-fourth of 203 cases of measles in a metropolitan country. Seventy cases occurred in two schools where 99% of the students were vaccinated. We analyzed countywide data to...


Read the Article

Other Topics